BACKGROUND AND OBJECTIVES: Multiple Sclerosis is a disease characterized by multifocal areas of demyelination in the brain and spinal cord, with associated inflammatory cell infiltrates, reactive gliosis, and axonal degeneration. It typically presents in young adults with episodic neurologic dysfunction, our aim is to find new simple method to treat multiple sclerosis by hematopoietic stem cells derived from peripheral blood. METHODS AND RESULTS: 50 patients suffering from multiple sclerosis worsening despite pharmacological treatment were treated by means of several intrathecal injections of peripheral blood cells harvested by aphaeresis after G-CSF(granulocyte colony stimulating factor) treatment. 24 patients (48% ) had a reduction of EDSS score. 8 patients had a relapse, but it was milder than usual and more easily controlled by cortisone. CONCLUSIONS: Since mesenchymal cells increase in the peripheral blood after G-CSF stimulation, a peripheral blood harvest seems easier and cheaper than mesenchymal cells cultivation prior to the injection. It seems a reasonable treatment for progressive multiple sclerosis.
BACKGROUND AND OBJECTIVES:Multiple Sclerosis is a disease characterized by multifocal areas of demyelination in the brain and spinal cord, with associated inflammatory cell infiltrates, reactive gliosis, and axonal degeneration. It typically presents in young adults with episodic neurologic dysfunction, our aim is to find new simple method to treat multiple sclerosis by hematopoietic stem cells derived from peripheral blood. METHODS AND RESULTS: 50 patients suffering from multiple sclerosis worsening despite pharmacological treatment were treated by means of several intrathecal injections of peripheral blood cells harvested by aphaeresis after G-CSF(granulocyte colony stimulating factor) treatment. 24 patients (48% ) had a reduction of EDSS score. 8 patients had a relapse, but it was milder than usual and more easily controlled by cortisone. CONCLUSIONS: Since mesenchymal cells increase in the peripheral blood after G-CSF stimulation, a peripheral blood harvest seems easier and cheaper than mesenchymal cells cultivation prior to the injection. It seems a reasonable treatment for progressive multiple sclerosis.
Authors: R Saccardi; T Kozak; C Bocelli-Tyndall; A Fassas; A Kazis; E Havrdova; E Carreras; A Saiz; B Löwenberg; P A W te Boekhorst; F Gualandio; H Openshaw; G Longo; F Pagliai; L Massacesi; E Deconink; J Ouyang; F J Z Nagore; J Besalduch; I A Lisukov; A Bonini; E Merelli; S Slavino; A Gratwohl; J Passweg; A Tyndall; A J Steck; M Andolina; M Capobianco; J L D Martin; A Lugaresi; G Meucci; R A Sáez; R E Clark; M N Fernandez; L Fouillard; B Herstenstein; V Koza; E Cocco; H Baurmann; G L Mancardi Journal: Mult Scler Date: 2006-12 Impact factor: 6.312
Authors: Krishna C Vallabhaneni; Sergey Tkachuk; Yulia Kiyan; Nelli Shushakova; Hermann Haller; Inna Dumler; Gabriele Eden Journal: Cardiovasc Res Date: 2010-11-18 Impact factor: 10.787
Authors: Peter A Walker; Matthew T Harting; Fernando Jimenez; Shinil K Shah; Shibani Pati; Pramod K Dash; Charles S Cox Journal: Stem Cells Dev Date: 2010-06 Impact factor: 3.272
Authors: Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén Journal: Lancet Date: 2008-05-10 Impact factor: 79.321
Authors: M Zakerinia; A Kamgarpour; H Nemati; H R Zare; M Ghasemfar; A R Rezvani; M Karimi; H Nourani Khojasteh; M Dehghani; R Vojdani; S Haghighat; N Namdari; J Rekabpoor; M Tavazo; S Amirghofran; Z Amirghofran; G A Yosefipour; M Ramzi Journal: Int J Organ Transplant Med Date: 2018-11-01
Authors: Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert Journal: Cells Date: 2022-07-11 Impact factor: 7.666